Chr. Hansen Holding (CPSE:CHR) - Cours de l'action, nouvelles et analyse

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

CHR Aperçu des actions

Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. Plus de détails

CHR analyse fondamentale
Score flocon de neige
Évaluation	0/6
Croissance future	0/6
Performances passées	3/6
Santé financière	4/6
Dividendes	4/6

Récompenses

Les bénéfices ont augmenté de 0.8% au cours de l'année écoulée

Analyse des risques

Les revenus ont diminué de 0.8% par an au cours des 5 dernières années

A un niveau d'endettement élevé

Historique instable des dividendes

Chr. Hansen Holding A/S Concurrents

Novonesis

CPSE:NSIS B

DKK 198.4b

Akzo Nobel

ENXTAM:AKZA

€9.6b

Nitto Denko

TSE:6988

JP¥1.7t

Zhejiang NHU

SZSE:002001

CN¥66.9b

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Chr. Hansen Holding
Historique des cours de bourse
Prix actuel de l'action	DKK 549.60
Plus haut sur 52 semaines	DKK 570.20
Plus bas sur 52 semaines	DKK 417.70
Bêta	0.33
1Variation sur 1 mois	-2.45%
Variation sur 3 mois	7.47%
Variation sur 1 an	7.09%
3Variation sur 3 ans	-4.02%
Variation sur 5 ans	-14.18%
Évolution depuis l'introduction en bourse	478.53%

Nouvelles et mises à jour récentes

Recent updates

Be Wary Of Chr. Hansen Holding (CPH:CHR) And Its Returns On Capital

Dec 31

Is Chr. Hansen Holding (CPH:CHR) Using Too Much Debt?

Dec 13

Chr. Hansen Holding (CPH:CHR) Will Be Hoping To Turn Its Returns On Capital Around

Jun 26

These 4 Measures Indicate That Chr. Hansen Holding (CPH:CHR) Is Using Debt Reasonably Well

May 21

Chr. Hansen Holding (CPH:CHR) Could Be Struggling To Allocate Capital

Mar 28

Chr. Hansen Holding's (CPH:CHR) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 14

Chr. Hansen Holding (CPH:CHR) Is Paying Out A Larger Dividend Than Last Year

Oct 29

Chr. Hansen Holding (CPH:CHR) Is Increasing Its Dividend To €7.04

Oct 15

Here's What's Concerning About Chr. Hansen Holding's (CPH:CHR) Returns On Capital

Sep 13

These 4 Measures Indicate That Chr. Hansen Holding (CPH:CHR) Is Using Debt Reasonably Well

Aug 29

There Are Reasons To Feel Uneasy About Chr. Hansen Holding's (CPH:CHR) Returns On Capital

Mar 06

Does Chr. Hansen Holding (CPH:CHR) Have A Healthy Balance Sheet?

Feb 19

Rendement pour les actionnaires

	CHR	DK Chemicals	DK Marché
7D	-1.2%	0.7%	4.0%
1Y	7.1%	-1.1%	8.0%

Rendement vs Industrie: CHR a dépassé le secteur Danish Chemicals qui a rapporté -1.1 % au cours de l'année écoulée.

Rendement vs marché: CHR a sous-performé le marché Danish qui a rapporté 8 % au cours de l'année écoulée.

Volatilité des prix

Is CHR's price volatile compared to industry and market?
CHR volatility
CHR Average Weekly Movement	3.0%
Chemicals Industry Average Movement	4.5%
Market Average Movement	4.2%
10% most volatile stocks in DK Market	10.5%
10% least volatile stocks in DK Market	2.5%

Cours de l'action stable: CHR n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de CHR ( 3% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

Fondée	Salariés	PDG	Site web
1843	3,834	Mauricio Graber	www.chr-hansen.com

Chr. Hansen Holding A/S Résumé des fondamentaux

Comment les bénéfices et les revenus de Chr. Hansen Holding se comparent-ils à sa capitalisation boursière ?
CHR statistiques fondamentales
Capitalisation boursière	DKK 72.33b
Bénéfices(TTM)	DKK 1.69b
Recettes(TTM)	DKK 9.94b

42.8x

Ratio P/E

7.3x

Ratio P/S

Le site CHR est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
CHR compte de résultat (TTM)
Recettes	€1.33b
Coût des recettes	€611.10m
Marge brute	€723.30m
Autres dépenses	€496.30m
Les revenus	€227.00m

Derniers bénéfices déclarés

Aug 31, 2023

Prochaine date de publication des résultats

Apr 04, 2024

Résultat par action (EPS)	1.72
Marge brute	54.20%
Marge bénéficiaire nette	17.01%
Ratio dettes/capitaux propres	52.0%

Quelles ont été les performances à long terme de CHR?

Voir les performances historiques et les comparaisons

Dividendes

1.4%

Rendement actuel des dividendes

60%

Ratio de distribution

This company is no longer active

CHR Aperçu des actions

Récompenses

Analyse des risques

Chr. Hansen Holding A/S Concurrents

CPSE:NSIS B

DKK 198.4b

ENXTAM:AKZA

€9.6b

TSE:6988

JP¥1.7t

SZSE:002001

CN¥66.9b

Historique des prix et performances

Nouvelles et mises à jour récentes

Chr. Hansen Holding A/S(CPSE:CHR) dropped from FTSE All-World Index (USD)

New major risk - Revenue and earnings growth

Chr. Hansen Holding A/S(CPSE:CHR) dropped from OMX Copenhagen 20 Index

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Chr. Hansen Holding A/S to Report Fiscal Year 2024 Results on Feb 06, 2025

Recent updates

Chr. Hansen Holding A/S(CPSE:CHR) dropped from FTSE All-World Index (USD)

New major risk - Revenue and earnings growth

Chr. Hansen Holding A/S(CPSE:CHR) dropped from OMX Copenhagen 20 Index

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Chr. Hansen Holding A/S to Report Fiscal Year 2024 Results on Feb 06, 2025

Be Wary Of Chr. Hansen Holding (CPH:CHR) And Its Returns On Capital

Is Chr. Hansen Holding (CPH:CHR) Using Too Much Debt?

Full year 2023 earnings: EPS misses analyst expectations

Chr. Hansen Holding A/S Declares Interim Dividend for the Period September 1, 2022 to August 31, 2023, Payable on October 17, 2023

Novozymes A/S and Chr. Hansen Announce Executive Leadership Team and Organizational Structure

Chr. Hansen Holding A/S Provides Earnings Guidance for the Period September 1, 2022 – August 31, 2023

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Chr. Hansen Holding (CPH:CHR) Will Be Hoping To Turn Its Returns On Capital Around

These 4 Measures Indicate That Chr. Hansen Holding (CPH:CHR) Is Using Debt Reasonably Well

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Chr. Hansen Holding (CPH:CHR) Could Be Struggling To Allocate Capital

Executive VP recently bought kr.555k worth of stock

First quarter 2023 earnings: EPS misses analyst expectations

Chr. Hansen Holding A/S Provides Revenue Guidance for 2022/23

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Investor sentiment improved over the past week

Chr. Hansen Holding A/S Approves Ordinary Dividend

Upcoming dividend of kr.7.04 per share

High number of new directors

Chr. Hansen Holding's (CPH:CHR) Shareholders Will Receive A Bigger Dividend Than Last Year

Chr. Hansen Holding A/S to Report Q1, 2023 Results on Dec 12, 2022

Chr. Hansen Holding (CPH:CHR) Is Paying Out A Larger Dividend Than Last Year

Investor sentiment improved over the past week

Chr. Hansen Holding (CPH:CHR) Is Increasing Its Dividend To €7.04

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Chr. Hansen Holding A/S Proposes Ordinary Dividend for 2021/22

Here's What's Concerning About Chr. Hansen Holding's (CPH:CHR) Returns On Capital

These 4 Measures Indicate That Chr. Hansen Holding (CPH:CHR) Is Using Debt Reasonably Well

A Look At The Intrinsic Value Of Chr. Hansen Holding A/S (CPH:CHR)

Chr. Hansen Holding A/S to Report Q2, 2023 Results on Apr 13, 2023

Third quarter 2022 earnings: EPS misses analyst expectations

Chr. Hansen Holding A/S Provides Earnings Guidance for the Full Year of Fiscal 2022

Capital Allocation Trends At Chr. Hansen Holding (CPH:CHR) Aren't Ideal

Chr. Hansen Holding (CPH:CHR) Seems To Use Debt Quite Sensibly

A Look At The Fair Value Of Chr. Hansen Holding A/S (CPH:CHR)

High number of new directors

Chr. Hansen Announces Lillie Li Valeur Steps Down from the Board of Directors

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

There Are Reasons To Feel Uneasy About Chr. Hansen Holding's (CPH:CHR) Returns On Capital

Does Chr. Hansen Holding (CPH:CHR) Have A Healthy Balance Sheet?

Rendement pour les actionnaires

Volatilité des prix

À propos de l'entreprise

Chr. Hansen Holding A/S Résumé des fondamentaux

42.8x

7.3x

Bénéfices et recettes

Dividendes

1.4%

60%